Although they only have live operations in 7 US States, the marketing prowess of bookmaker Pointsbet (ASX: PBH) is in full swing with a huge pipeline of more than 500,000 Americans that are ready to be tapped on the shoulder the moment they secure the relevant regulatory approvals. It’s that glorious time of the year
Read More
Clinical stage drug developers Pharmaxis (ASX: PXS) have had a busy quarter with two of their lead drug assets progressing through to the next stage of their clinical studies while sales of their existing products were up 395%. The Biotech’s cancer drug, PXS-5505 has progressed to a Phase 2a study in myelofibrosis patients following pleasing
Read More
Despite being one of the world’s most recognised milk powder brands, it’s only now that Bubs (ASX: BUB) is tapping into the cow milk powder market which is estimated to generate $20 billion in global sales annually. That’s because the $46.8 million in sales generated by Bubs in FY21 was primarily from their portfolio of
Read More
The rapidly increasing number of pet owners in Western Victoria will soon have access to new industry leading vet services with Apiam Animal Health (ASX: AHX) acquiring Horsham Veterinary Hospital as part of their expansion strategy in regional growth corridors. The acquisition will see Horsham Veterinary Hospital join eight other clinics owned by Apiam in
Read More
The XJO is expected to open lower this morning, following a pull back in the U.S last night. U.S futures sit in the green, giving hope that the move last night was a simple and healthy retracement, rather than something to be truly worried about. In the short term, if the U.S does continue to
Read More
Whilst medicinal cannabis might be all the rage currently, there is no shortage of other natural medicines. Kava is a plant native to the western Pacific islands and has been used in ceremonial drinks for centuries. The plant promotes relaxation thanks to kavapyrones, a substance that acts similar to alcohol in the brain, which has
Read More